CFFT to Expand Clinical Research Capabilities Nationwide
| 2 min read

To enable greater patient involvement in clinical drug trials, and speed the development of new therapies, Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), a nonprofit affiliate of the Cystic Fibrosis Foundation, is investing more than $3 million to expand its clinical research network.

CFFT is making awards to 45 sites in the United States and one in Canada, to help the centers further develop their ability to conduct safe and effective cystic fibrosis clinical trials through training, resources and infrastructure support. The U.S. award recipients are already part of a national network of care centers accredited by the CF Foundation.

The new research sites will allow the Foundation to draw on a much larger pool of patients, and in turn, give patients greater opportunities to help advance progress. The new sites are located in every part of the country, including: Arizona, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky, Michigan, Nebraska, New Hampshire, New Jersey, New Mexico, Oklahoma, Oregon, South Carolina, South Dakota, Tennessee, Virginia, West Virginia and Wisconsin.

“To help promising drugs move swiftly from the research and testing stage into the hands of patients who need them, we need more people with cystic fibrosis to take part in clinical trials,” said Robert J. Beall, Ph.D., president and CEO of the CF Foundation. “Without patient volunteers, research and progress are not possible. Patients are the key.”

In addition to its care center network, the CF Foundation also has a specialized clinical research network of 18 centers that conduct Phase 1 and Phase 2 clinical trials in 13 states.

Share this article
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT)
Recent news
CF Foundation Provides Up to $3.9M to TB Alliance to Further Develop an NTM Drug
News | 2 min read
CF Foundation Advocates to Protect Needs of People With CF in Post-Pandemic Medicaid Redeterminations
News | 5 min read
FDA Approves Kalydeco for Infants as Young as 1 Month
News | 4 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.